BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24744646)

  • 1. Immunosuppressive treatment in children with acquired aplastic anemia.
    Yıldırmak Y; Erdem E; Telhan L; Kepekçi L
    Turk J Haematol; 2012 Jun; 29(2):150-5. PubMed ID: 24744646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive therapy (IST) in adult patients with acquired aplastic anemia (AA): A single-center experience over the past 15 years.
    Alashkar F; Oelmüller M; Herich-Terhürne D; Turki AT; Schmitz C; Vance C; Dührsen U; Röth A
    Eur J Haematol; 2019 Jul; 103(1):18-25. PubMed ID: 30977158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunosupressive therapy of aplastic anemia patients: successes and failures (single center experiment 2007-2016)].
    Mikhaylova EA; Fidarova ZT; Abramova AV; Luchkin AV; Troitskaya VV; Dvirnyk VN; Galtseva IV; Kliasova GA; Kovrigina AM; Kulikov SM; Chabaeva YА; Parovichnikova EN; Savchenko VG; Obukhova TN
    Ter Arkh; 2020 Sep; 92(7):4-9. PubMed ID: 33346440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of children with aplastic anemia treated with immunosuppressive therapy.
    Pongtanakul B; Das PK; Charpentier K; Dror Y
    Pediatr Blood Cancer; 2008 Jan; 50(1):52-7. PubMed ID: 17941069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rabbit antithymocyte globulin versus horse antithymocyte globulin for treatment of acquired aplastic anemia: a retrospective analysis.
    Vallejo C; Montesinos P; Polo M; Cuevas B; Morado M; Rosell A; Xicoy B; Díez JL; Salamero O; Cedillo Á; Martínez P; Rayón C;
    Ann Hematol; 2015 Jun; 94(6):947-54. PubMed ID: 25672649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic efficacy evaluation of rabbit anti-thymocyte globulin combined with cyclosporine A in children with aplastic anemia].
    Fu RT; Xue HM; Xu HG; Huang K; Fang JP; Huang SL; Chen C
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):426-30. PubMed ID: 23628047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine.
    Scheinberg P; Wu CO; Nunez O; Young NS
    J Pediatr; 2008 Dec; 153(6):814-9. PubMed ID: 18672253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of combination therapy with anti-thymocyte globulin and cyclosporine A as a first-line treatment in adult patients with aplastic anemia: a comparison of rabbit and horse formulations.
    Suzuki T; Kobayashi H; Kawasaki Y; Okazuka K; Hatano K; Fujiwara S; Oh I; Ohmine K; Kanda Y
    Int J Hematol; 2016 Oct; 104(4):446-53. PubMed ID: 27338268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
    Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
    Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eltrombopag in Combination with Rabbit Anti-thymocyte Globulin/Cyclosporine A in Immunosuppressive Therapy-naïve Patients with Aplastic Anemia in Japan.
    Imada K; Obara N; Iida H; Imajo K; Maeda T; Usuki K; Fanghong Z; Hombo Y; Tajima T; Kumagai A; Matsuda A; Nakao S
    Intern Med; 2021 Apr; 60(8):1159-1168. PubMed ID: 33229810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nationwide survey on the use of horse antithymocyte globulins (ATGAM) in patients with acquired aplastic anemia: A report on behalf of the French Reference Center for Aplastic Anemia.
    Peffault de Latour R; Tabrizi R; Marcais A; Leblanc T; Lamy T; Mohty M; Tavitian S; Jubert C; Pasquet M; Galambrun C; Nguyen S; Cahn JY; Braun T; Deconinck E; Bay JO; Sicre de Fontbrune F; Barraco F; Socié G
    Am J Hematol; 2018 May; 93(5):635-642. PubMed ID: 29377260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Outcome of Acquired Post-Immunosuppressive-Therapy Aplastic Anemia in Pediatric Patients: A 13-Year Experience in Two Southern China Tertiary Care Centers.
    Huang J; Huang L; Liu S; Lin S; Cheng Y; Jiang X; Xue H; Li C; Chen C
    Int J Gen Med; 2021; 14():3133-3144. PubMed ID: 34239322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithymocyte globulin and cyclosporine in children with aplastic anemia: a developing country experience.
    Sharma R; Chandra J; Sharma S; Pemde H; Singh V
    J Pediatr Hematol Oncol; 2012 Mar; 34(2):93-5. PubMed ID: 22278201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profile and Predictors of Infection Following Anti-thymocyte Globulin or Anti-lymphocyte Globulin with Cyclosporine in Aplastic Anemia.
    Lionel SA; Selvarajan S; Korula A; Kulkarni U; Devasia A; Abubacker FN; Abraham A; Mathews V; Lakshmi KM; George B
    Indian J Hematol Blood Transfus; 2023 Jul; 39(3):419-428. PubMed ID: 37304482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective multicenter trial comparing repeated immunosuppressive therapy with stem-cell transplantation from an alternative donor as second-line treatment for children with severe and very severe aplastic anemia.
    Kosaka Y; Yagasaki H; Sano K; Kobayashi R; Ayukawa H; Kaneko T; Yabe H; Tsuchida M; Mugishima H; Ohara A; Morimoto A; Otsuka Y; Ohga S; Bessho F; Nakahata T; Tsukimoto I; Kojima S;
    Blood; 2008 Feb; 111(3):1054-9. PubMed ID: 17989314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive therapy for pediatric aplastic anemia: a North American Pediatric Aplastic Anemia Consortium study.
    Rogers ZR; Nakano TA; Olson TS; Bertuch AA; Wang W; Gillio A; Coates TD; Chawla A; Castillo P; Kurre P; Gamper C; Bennett CM; Joshi S; Geddis AE; Boklan J; Nalepa G; Rothman JA; Huang JN; Kupfer GM; Cada M; Glader B; Walkovich KJ; Thompson AA; Hanna R; Vlachos A; Malsch M; Weller EA; Williams DA; Shimamura A
    Haematologica; 2019 Oct; 104(10):1974-1983. PubMed ID: 30948484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults.
    Zhu X; Guan J; Xu J; Wei J; Jiang L; Yin J; Zhao L; Zhang Y
    Blood Cells Mol Dis; 2014 Sep; 53(3):157-60. PubMed ID: 24931461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive therapy for aplastic anemia: a single-center experience from western India.
    Shah S; Jain P; Shah K; Patel K; Parikh S; Patel A; Panchal H; Anand A
    Ann Hematol; 2019 Jan; 98(1):41-46. PubMed ID: 30173288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparable outcomes with low-dose and standard-dose horse anti-thymocyte globulin in the treatment of severe aplastic anemia.
    Jain A; Jandial A; Mani T; Kishore K; Singh C; Lad D; Prakash G; Khadwal A; Das R; Varma N; Varma S; Malhotra P
    Blood Res; 2024 Feb; 59(1):6. PubMed ID: 38485832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rabbit antithymocyte globulin treatment in childhood acquired severe aplastic anemia.
    Karapinar DY; Karadaş N; Ay Y; Akin M; Balkan C; Aydinok Y; Kavakli K
    Pediatr Hematol Oncol; 2014 Feb; 31(1):20-8. PubMed ID: 23627541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.